Neonataldiagnostik-Unternehmen InfanDx AG etabliert wissenschaftlichen Beirat
19 janv. 2022 04h00 HE
|
AKAMPION
Team erfahrener wissenschaftlicher Experten zur Beratung von InfanDx bei diagnostischem Bedarf und Produktkonzepten in der neonatalen Akut- und IntensivmedizinSchwerpunkte der Eröffnungssitzung:...
Eisbach Bio and MD Anderson announce strategic collaboration to develop medicines targeting epigenetic machinery in oncology
18 janv. 2022 09h00 HE
|
AKAMPION
MUNICH and HOUSTON; January 18, 2022 ― Eisbach Bio GmbH and The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration to jointly discover and develop...
BellaSeno Announces Publication of First-in-Human Data of its Lead Program Senella
07 déc. 2021 04h00 HE
|
AKAMPION
- Successful initial treatment of pectus excavatum patient in Australia - Data published in the European Journal of Plastic Surgery confirms Bellaseno’s novel approach in soft tissue engineering ...
ImmunOs Therapeutics Appoints Steve Coats, PhD, as Chief Development Officer
06 déc. 2021 04h00 HE
|
AKAMPION
- Company adds significant immunotherapy development expertise to its management team- Clinical trial of lead compound IOS-1002 to start in 2022 Schlieren (Zurich Area), Switzerland. – December...
ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity In Vivo and In Vitro
15 nov. 2021 03h00 HE
|
AKAMPION
- Promising data presented at Society for Immunotherapy of Cancer 36th Annual Meeting (SITC) - Multi-functional agent targeting three innate immune checkpoint receptors - Potential as monotherapy and...
Curexsys Appoints Christian Eckert as Chief Operating Officer
20 oct. 2021 04h00 HE
|
AKAMPION
- Strengthened management team headed by Jörg Neermann as CEO Goettingen, Germany, October 20, 2021 - Curexsys GmbH, a leader in the emerging field of therapeutic exosomes, today announced the...
ImmunOs Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC)
13 oct. 2021 04h15 HE
|
AKAMPION
- Preclinical data highlighting mode-of-action of lead program iosH2 Schlieren (Zurich Area), Switzerland. – October 13, 2021 – ImmunOs Therapeutics AG, a Swiss biotechnology company developing...
ImmunOs Therapeutics Appoints Jeffrey Abbey as Chief Operating Officer, Establishes Clinical Advisory Board
01 sept. 2021 04h00 HE
|
AKAMPION
- Company prepares for further growth and entry into clinical development- Prof. Andrew Scott, Dmitriy Zamarin, MD, PhD, Prof. Dr. med. Dirk Jäger, and Jeffrey M. Bockman, PhD, appointed as clinical...
Neonatal Diagnostics Company InfanDx AG Appoints Dr. Gunter Weiss as COO
04 août 2021 04h00 HE
|
AKAMPION
Dr. Weiss brings more than 15 years of experience in biomarker and in vitro diagnostics development Company launched targeted recruiting campaign for next phase of corporate life cycle Cologne,...
Neonatal-Diagnostik-Unternehmen InfanDx AG ernennt Dr. Gunter Weiss zum Chief Operating Officer
04 août 2021 04h00 HE
|
AKAMPION
Dr. Weiss verfügt über mehr als 15 Jahre Erfahrung mit der Entwicklung von Biomarkern und In-vitro-Diagnostika Unternehmen hat gezielte Rekrutierungskampagne für die nächste Phase der...